A Novel Paradigm for the Treatment of Osteoarthritis
At Kolon TissueGene, we are developing advanced cell therapies to target various orthopedic diseases and degenerative disorders.
explore our platform technology
An Allogeneic Cell and Gene Therapy for Osteoarthritis of the Knee
TG-Cis designed to conveniently and effectively treat osteoarthritis of the knee by reducing pain, increasing function, and slowing the progression of the disease.
learn more about TG-C
Developing Advanced Cell Therapies for the Treatment of Orthopedic Disorders and Unmet Medical Needs
Kolon TissueGene is a Maryland-based biopharmaceutical company developing clinical-stage advanced cell therapies.
TG-C